L
Lorenzo G. Mantovani
Researcher at University of Milan
Publications - 361
Citations - 38356
Lorenzo G. Mantovani is an academic researcher from University of Milan. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 51, co-authored 324 publications receiving 26740 citations. Previous affiliations of Lorenzo G. Mantovani include University of Naples Federico II & University of Milano-Bicocca.
Papers
More filters
Journal ArticleDOI
Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry.
Jean-Yves Le Heuzey,Jean-Pierre Bassand,Jean-Baptiste Berneau,P Cozzolino,Lucia Sara D'Angiolella,Bernard Doucet,Lorenzo G. Mantovani,Michel Martelet,Joseph Mouallem,Jean-Joseph Muller,Karen S. Pieper,Garfield-Af Investigators +11 more
TL;DR: Patients enrolled in France had higher rates of mortality and stroke/systemic embolism than in GARFIELD-AF overall, whereas the rates of major bleeding were similar, and the highest cost was associated with inpatients.
Journal ArticleDOI
Psoriatic arthritis: Pharmacoeconomic considerations
TL;DR: Recent pharmacoeconomic studies have demonstrated that TNF-α blockers are cost-effective treatment options for the musculoskeletal and cutaneous manifestations of psoriatic disease.
Journal ArticleDOI
Peripheral arterial disease in diabetic patients: a long-term population-based study on occurrence, outcomes and cost.
Enrico Maria Marone,P Cozzolino,Roberta Ciampichini,V. Chiodini,Roberto Ferraresi,Luigi F. Rinaldi,Lorenzo G. Mantovani,Giancarlo Cesana +7 more
TL;DR: The present study gives an up-to-date description of the dramatic epidemiologic and economic burden of PAD in diabetic subjects using a truly population-based data and longitudinal follow-up of up to 9 years.
Journal ArticleDOI
Systematic review: economic evaluations of HCV screening in the direct‐acting antivirals era
Paolo Cortesi,Roberta Barca,Giulia Giudicatti,Sergio Mossini,A. Ciaccio,Sergio Iannazzo,Mariangela Micale,Giancarlo Cesana,Lorenzo G. Mantovani +8 more
TL;DR: The World Health Organization estimated that 90% of the infected people needs to be diagnosed and 80% need to be treated to reach the aim of hepatitis C virus (HCV) elimination by 2030.
Journal ArticleDOI
Major Diabetes Complications Have an Impact on Total Annual Medical Cost of Type 2 Diabetes
Andrea Morsanutto,Patrizia Berto,Stefania Lopatriello,Dario Voinovich,Renzo Gelisio,Lorenzo G. Mantovani +5 more
TL;DR: A retrospective longitudinal cost-of-care study in a diabetologic center in Italy finds that the occurrence of diabetes-related comorbidities in type 2 diabetic patients are associated with an increase in average annual medical cost.